Skip to content

Evadri Bladder Control Systems

by Hollister, Inc. 510(k)

Active United States

510(k) K050483

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK050483 Date12 Apr 2005ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
KPI
Device Class
Class II
Regulation
21 CFR Part 876.5320
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Evadri Bladder Control Systems are non-implantable, electrical stimulators designed for managing urinary incontinence. These devices deliver electrical stimulation or electromyographic (EMG) biofeedback to strengthen pelvic floor muscles, improving bladder control in patients with neurogenic or stress incontinence.

The systems are intended for use in clinical settings such as urology and gastroenterology practices, where trained professionals apply them to patients. Supplied as reusable medical devices, they comply with FDA 510(k) clearance under regulation number 876.5320 and are classified as Class II devices. Storage and handling follow standard medical device protocols to ensure functionality and sterility.

Other devices from Hollister, Inc.

See all devices from Hollister, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of urinary incontinence can the Evadri Bladder Control Systems help manage, and how does it work?

    The Evadri Bladder Control Systems are designed specifically for managing neurogenic or stress incontinence by delivering electrical stimulation or EMG biofeedback. These devices work by strengthening pelvic floor muscles through targeted electrical impulses, helping patients regain better bladder control. They are intended for use in clinical settings like urology and gastroenterology practices, where trained professionals apply them to patients.

  • Are the Evadri Bladder Control Systems reusable or single-use, and how should they be stored?

    The Evadri Bladder Control Systems are reusable medical devices, meaning they are designed for repeated use in clinical settings. Proper storage and handling follow standard medical device protocols to maintain functionality and ensure sterility. Since they are not single-use, they must be cleaned, disinfected, and stored according to manufacturer guidelines to prevent contamination and preserve performance.

  • What regulatory pathway was followed for FDA clearance of the Evadri Bladder Control Systems, and what classification does it hold?

    The Evadri Bladder Control Systems received FDA 510(k) clearance under regulation number 876.5320, which classifies them as Class II devices. The clearance was granted through a traditional 510(k) review pathway, with a decision of Substantially Equivalent (SESE). This means the device was determined to be as safe and effective as a legally marketed predicate device.

  • In which medical specialties are the Evadri Bladder Control Systems primarily used, and where can they be applied?

    The Evadri Bladder Control Systems are primarily intended for use in urology and gastroenterology practices, as indicated by their advisory committee classification. They are designed for application in clinical settings where trained professionals can administer electrical stimulation or EMG biofeedback to patients with urinary incontinence, helping manage neurogenic or stress-related bladder control issues.